article thumbnail

Transforming pharmaceutical manufacturing: The AI revolution

European Pharmaceutical Review

Revolutionising quality control In the backdrop of stringent quality standards and regulatory demands inherent to pharmaceutical manufacturing, the addition of AI technologies introduce a paradigm shift. Tuijin Jishu/Journal of Propulsion Technology, 44(3), 1384-1392.

article thumbnail

The Future of Biosimilars Marketing

PM360

biosimilars market is evolving rapidly and pharma marketing programs need to evolve as well to better meet physician needs. An effective and efficient solution to this challenge for biosimilar manufacturers is a patient-first approach that goes above and beyond the capabilities of traditional engagement approaches.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

What We’re Watching for 2024 – Top Trends in Market Access

Eversana Intouch

In the rapidly changing landscape of global markets, staying ahead of the curve is crucial for businesses aiming to expand and thrive. As we step into 2024, the realm of market access undergoes dynamic shifts influenced by technological advancements, policy changes, and evolving consumer behaviors.

article thumbnail

Inspira™ Technologies Begins Manufacturing of the ALICE™ CPB Device, ahead of planned 2023 FDA submission

Legacy MEDSearch

a groundbreaking respiratory support technology company, announced today that it has begun the manufacturing process for the ALICE CPB (Cardiopulmonary Bypass) device (the “ALICE device”) to undergo the Verification and Validation phase prior to its planned 2023 submission to the U.S. Inspira Technologies OXY B.H.N. and Israel.

article thumbnail

Pharma manufacturing can digitalise its way round the next crisis

pharmaphorum

The turbulence of the last three years can make it seem as though pharma manufacturers have been operating in an atmosphere of non-stop crisis. The net effect has been to stimulate change in every aspect of the pharma industry – an industry not exactly known for its embrace of manufacturing innovation.

article thumbnail

Affordability Programs Need a Technology Makeover

PM360

Manufacturer assistance programs are designed to make treatments more affordable, yet only about 10% of these dollars are used by patients. Pharmaceutical manufacturers know how important adherence to a treatment plan is and to help patients afford medications, manufacturer assistance programs are designed to make treatments more affordable.

article thumbnail

Buy And Sell Metal in The Stock Market

Contrarian Sales Techniques

Trading metal in the stock market is different from trading commodities like commodity1 , commodity2 or this commodity in several ways. Third, metal is often traded in the stock market through exchange-traded funds (ETFs) or stocks of mining companies, while commodities are typically traded on commodity exchanges through futures contracts.